ENTA Projected Dividend Yield
Enanta Pharmaceuticals Inc ( NASDAQ : ENTA )Enanta Pharmaceuticals is a biotechnology company that engaged in the discovery and development of small molecule drugs for the treatment of viral infections. Co.'s primary wholly-owned research and development programs are in virology, namely respiratory syncytial virus, severe acute respiratory syndrome coronavirus 2, hepatitis B virus and human metapneumovirus. Co.'s out-licensed products include two protease inhibitors, which are developed through Co.'s Collaborative Development and License Agreement with AbbVie have been clinically tested, manufactured, and commercialized by AbbVie as part of its combination regimens for hepatitis C virus. 20 YEAR PERFORMANCE RESULTS |
ENTA Dividend History Detail ENTA Dividend News ENTA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |